6Terada N,Lucas JJ,Szepesi A,et al.Rapamycin blocks cell cycle progression of activated T cell prior to events characteristic of the middle to late G1 phase of the cycle [J].J Cell Physiol,1993,154(1): 7-15.
7Huang S,Houghton PJ.Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic[J].Curr Opin Investig Drugs,2002,3(2):295-304.
8Chen F,Ornasa M,Kondo N,et al.Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation[J].Ann Thorac Surg,2009,87(1):6-7.
9Hay N,Sonenberg N.Upstream and downstream of mTOR[J].Genes Dev,2004,18(16): 1 926-1 945.
10Vignot S,Faivre S,Aguirre D,et al.mTOR-targeted therapy of cancer with rapamycin derivatives[J].Ann Oncol,2005,16(4):525-537.
